NYSCF Press Releases
NYSCF designed and has built a revolutionary, high-throughput robotic platform that automates and standardizes the process of transforming patient samples into stem cells. This one-of-a-kind system addresses challenges that face the entire field, and is now an essential resource that NYSCF provides in collaborations with leading academic and industry partners…
NYSCF's Initiative on Women in Science and Engineering, or IWISE, brings together leading women and men in science, engineering and medicine to address gender equality in these fields.  Working towards this goal, the IWISE Working Group published a paper in Cell Stem Cell recommending seven actionable strategies for advancing women in science, engineering,…
For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they developed an accelerated protocol to induce these stem cells into becoming oligodendrocytes, the myelin-forming cells of the central nervous system implicated in multiple sclerosis…
Susan Solomon, CEO of The New York Stem Cell Foundation, presented on Wednesday June 27 at TEDGlobal in Edinburgh, Scotland. The international wing of the famed TED conference brought 76 innovative thought-leaders from across the world together to share their expertise in fields ranging from cell biology to classical music.…
The NYSCF Research Institute is partnering with the Stanley Center at the Broad Institute of MIT and Harvard to develop a stem cell resource to study schizophrenia and psychiatric disorders. NYSCF is generating hundreds of stem cell lines from skin samples of patients provided by the Stanley Center, which will…
NYSCF and the Charcot-Marie-Tooth Association (CMTA), a patient-led disease foundation with a mission to advance research on genetic neuropathies leading to the development of new therapies, partnered to research and, ultimately, find cures for Charcot-Marie-Tooth disease and other genetic neuropathies. The immediate aim of the collaboration is to develop a…
NYSCF scientists, in collaboration with others, compared stem cells created using two different methods: induced pluripotent stem (iPS) cells and stem cells created by somatic cell nuclear transfer (SCNT). The scientists compared the two methods using three different sources of cells, showing that the mutations seen in reprogrammed cells are likely…
NYSCF scientists, in collaboration with others, successfully created a human cell model of sporadic Parkinson's disease in a dish. The scientists had the unique opportunity to study contributing factors to Parkinson's disease through a set of identical twins, one of which has the disease.  The study, published as the cover story…
The NYSCF Research Institute, through the launch of its repository in 2015, will provide the largest-ever number of stem cell lines available to the scientific research community. Initially, over 600 induced pluripotent stem (iPS) cell lines and 1,000 cultured fibroblasts from over 1,000 unique human subjects will be made available,…
The 2014 NYSCF - Robertson Investigators were announced at NYSCF’s Ninth Annual Gala and Science Fair, held at Jazz at Lincoln Center in Manhattan. Each Investigator will receive a $1.5 million award, which will be disbursed over the next five years, which will enable them to expand their laboratories and train…
Page 1 of 9
You are here: News Press Releases